1.Extranodal Marginal Zone Lymphoma Occurring along the Trachea and Central Airway.
Ji Young KANG ; Hyun Jin PARK ; Kyo young LEE ; Sook Young LEE ; Seung Joon KIM ; Sung Hak PARK ; Young Kyoon KIM
Yonsei Medical Journal 2008;49(5):860-863
Extranodal marginal zone lymphoma is a low-grade B cell lymphoma that presents with an indolent clinicopathologic nature. Although this tumor can occur in various sites, including the gastrointestinal tract and lungs, it develops and spreads extremely rarely along the trachea and central airway. We report a case of extranodal lymphoma of mucosa-associated lymphoid tissue with tracheobronchial involvement. An 83-year-old woman presented with a cough and dyspnea. Bronchoscopic evaluation confirmed diffuse, multiple nodular lesions in both the trachea and large bronchi, and she was diagnosed with an extranodal marginal zone lymphoma of the tracheobronchial tree. After systemic chemotherapy, she survived for more than 18 months.
Aged, 80 and over
;
Bronchial Diseases/drug therapy/*pathology/radiography
;
Female
;
Humans
;
Lymphoma, B-Cell, Marginal Zone/drug therapy/*pathology/radiography
;
Radiography, Thoracic
;
Tracheal Diseases/drug therapy/*pathology/radiography
2.Rituximab-CHOP Induced Interstitial Pneumonitis in Patients with Disseminated Extranodal Marginal Zone B Cell Lymphoma.
Kwang Min KIM ; Ho Cheol KIM ; Kyung Nyeo JEON ; Hoon Gu KIM ; Jung Hun KANG ; Jong Ryeal HAHM ; Gyeong Won LEE
Yonsei Medical Journal 2008;49(1):155-158
A 69-year-old male was diagnosed in February 2004 with stage IV extranodal marginal zone B cell lymphoma involving the mediastinal nodes, lung parenchyma and bone marrow with high LDH. Shortness of breath developed following the 5th course of Rituximab-CHOP chemotherapy (cyclophosphamide, Vincristine, Doxorubicin, Prednisolone). Bronchoscopy guided transbronchial lung biopsy revealed interstitial thickening and type II pneumocyte activation, compatible with interstitial pneumonitis. After treatment with prednisolone a complete resolution of the dyspnea was observed. The patient was well on routine follow-up at the outpatient clinic, with no progression of lymphoma or interstitial pneumonitis.
Aged
;
Antibodies, Monoclonal/*adverse effects/*therapeutic use
;
Antineoplastic Combined Chemotherapy Protocols/*adverse effects/*therapeutic use
;
Biopsy
;
Cyclophosphamide/adverse effects/therapeutic use
;
Doxorubicin/adverse effects/therapeutic use
;
Humans
;
Lung Diseases, Interstitial/*chemically induced/*pathology/radiography/surgery
;
Lymphoma, B-Cell, Marginal Zone/*drug therapy
;
Male
;
Prednisone/adverse effects/therapeutic use
;
Tomography, X-Ray Computed
;
Vincristine/adverse effects/therapeutic use